The management pathway is clinical, not commercial. Observation, medical treatment, and enhancement are applied in sequence, least invasive first, based on the type and stability of the problem.
The Decision Framework at a Glance
- Observation – Indication: Vision still improving; residual error minor; patient functionally satisfied; cornea not yet stable. BFV Timing: Review at Month 1, Month 3, Month 6.
- Medical treatment – Indication: Corneal haze; dry eye; ocular surface inflammation; healing delay. BFV Timing: Initiated at the appointment where finding is made; serial OCT at 6-8 week intervals.
- Enhancement – Indication: Stable residual refractive error; adequate stromal tissue (≥250 microns residual bed); patient symptomatic and motivated. BFV Timing: Eligibility assessed at Month 3 (LASIK) or Month 6+ (PRK/TransPRK).
Observation
Observation is appropriate when vision is still improving within the expected postoperative trajectory, residual error is within the range of biological variability, and corneal stability has not yet been confirmed. Enhancement before topographic stability is confirmed carries a measurably higher risk of an unpredictable second outcome. ¹
In practical terms: Being told to ‘wait and see’ is not inaction. Corneal stability takes time to establish. Acting before it does is the mistake.
Medical Treatment
Medical management addresses the cause of the suboptimal outcome, not the symptom:
- Corneal haze: prednisolone acetate 1% with slow taper; serial OCT; UV protection
- Dry eye: lubricants, anti-inflammatory drops, omega-3 supplementation, punctal occlusion if indicated
- Ocular surface inflammation: short-course topical steroid with review at 4 weeks
Medical management is non-invasive and always precedes any surgical decision where it is clinically appropriate.
Enhancement Surgery
Enhancement is a defined clinical intervention, not a retry. Eligibility criteria are applied consistently and are not adjusted based on patient preference or commercial considerations. ²
Eligibility requires all of the following:
- Topographic stability on serial mapping – no measurable change between two consecutive readings at least 6-8 weeks apart
- Residual stromal bed depth of at least 250 microns following any further ablation
- Refractive error within the range of laser correction
- Functional symptoms that are attributable to the residual refractive error
Blue Fin Vision® specifically: At Blue Fin Vision®, PRK and TransPRK enhancement eligibility is formally assessed at the Month 6 review, not the Month 3 review, because surface ablation healing continues for longer than LASIK. This is a clinical distinction that matters: enhancement assessed too early in PRK patients produces less predictable outcomes. The Month 6 threshold is non-negotiable at this practice.
When things are straightforward, many clinics perform well. When they are not, that is where systems, experience and accountability matter most.
Frequently Asked Questions
How do I know when I have moved from ‘observation’ to needing medical treatment?
At your scheduled follow-up appointments, Mr Hove reviews your refraction, slit lamp findings, and OCT imaging. If findings cross a defined threshold, for example, early haze on OCT at Month 1, or a refractive result outside the expected range at Month 3, the management plan is adjusted at that appointment. You do not need to identify this yourself.
What if I feel my vision is not good enough but I am told to keep observing?
This is a common and reasonable concern. The clinical rationale is that acting before corneal stability is confirmed risks worsening the outcome. Mr Hove explains the specific finding that indicates continued observation and provides a clear timeline and criteria for moving to the next pathway. If you remain concerned, a second clinical opinion can be arranged.
Can I have both medical treatment and enhancement at the same time?
No. Medical treatment must precede enhancement. Active corneal haze or significant dry eye is a contraindication to laser enhancement until the surface is stable and the condition is resolved. The sequence, medical first, enhancement after, is a clinical requirement, not a preference.
References
- Randleman JB, Woodward M, Lynn MJ, Stulting RD. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008;115(1):37-50.
- Albé E, Carones F, Marchini G, Tassinari G, Mastropasqua L, Rama P. Enhancement after laser in situ keratomileusis: indications and outcomes. J Cataract Refract Surg. 2009;35(10):1717-1723.
- Dupps WJ Jr, Wilson SE. Biomechanics and wound healing in the cornea. Exp Eye Res. 2006;83(4):709-720.
- Stulting RD, Carr JD, Thompson KP, Waring GO, Wiley WM, Walker JG. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology. 1999;106(1):13-20.
- Hersh PS, Brint SF, Maloney RK, Durrie DS, Gordon M, Michelson MA, Thompson VM, Berkeley RB, Schein OD, Steinert RF. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. Ophthalmology. 1998;105(8):1512-1522.
Related Topics
- Corneal Haze After TransPRK
- When Things Are Not Perfect: Understanding Risk, Recovery and Responsibility
- What Happens If Something Goes Wrong After Laser Eye Surgery?
- Corneal Haze After PRK or TransPRK: Causes, Treatment, and Outcomes
- Is Corneal Haze Permanent After Laser Eye Surgery?
- When Results Are Suboptimal: Observation, Medical Treatment, or Enhancement
- How Often Do Serious Complications Occur in Laser Eye Surgery?
- Why Safe Eye Surgery Depends on Systems, Not Just a Good Surgeon
- The Blue Fin Vision® Advantage: How Our System Protects You
- Why Specialist Access Matters When Eye Surgery Gets Complicated
- What Happens If Your Surgeon Needs a Second Opinion?
- Patient Case: Corneal Haze After TransPRK – Messages, OCT, and Outcome
- When Recovery Doesn’t Go to Plan
- How Months-Long Follow-Up Changes Outcomes
- Does Laser Eye Surgery Always Go Perfectly?
- Why No Surgeon Can Guarantee Perfect Vision
- What Good Aftercare Looks Like After Laser Eye Surgery
- Are Enhancements Included After Laser Eye Surgery?
- When Is an Enhancement Needed?
- How Often Do Patients Need Enhancements?
- Why Most Clinics Don’t Talk Openly About Complications
- What Truly Separates Great Clinics When Things Go Wrong
